USPTO serial 79396291
LYBRIZMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 18, 2025
- Examiner
- BLAKESLEE, RICHARD A
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LYBRIZMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700DENVER, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, pharmaceutical preparations for treatment and prevention of stomach- and bowel-related disorders and gastrointestinal diseases and disorders in humans, namely, Short Bowel Syndrome (SBS) | ACTIVE | — |
| 010 | Devices for introducing pharmaceutical preparations, namely, infusion and injection devices for administering drugs for treatment and prevention of stomach- and bowel-related disorders and gastrointestinal diseases and disorders in humans, namely, Short Bowel Syndrome (SBS) | ACTIVE | — |
| 044 | Medical and pharmaceutical services, namely, medical treatment of stomach- and bowel-related disorders and gastrointestinal diseases and disorders in humans, namely, Short Bowel Syndrome (SBS) and pharmaceutical consultation for the prevention of stomach- and bowel-related disorders and gastrointestional diseases and disorders in humans, namely, Short Bowel Syndrome (SBS); providing medical and pharmaceutical advice, in the fields of treatment and prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, namely, Short Bowel Syndrome (SBS) | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ZEALAND PHARMA A/S
- Other trademarks owned by ZEALAND PHARMA A/S
- Other trademarks owned by ZEALAND PHARMA A/S
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named LYBRIZMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 22, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 22, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 18, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 30, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 29, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 19, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 18, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 18, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 28, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 28, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 22, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 7, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 13, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 13, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 25, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 25, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 25, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 11, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 25, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 25, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 28, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 27, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 11, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 23, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |